rapid test for detecting total immunoglobulins directed towards the nucleocapsid protein (N) of severe acute syndrome coronavirus 2 (SARS CoV-2) was developed, based on a multi-target lateral flow immunoassay comprising two test lines. Both test lines bound to several classes of immunoglobulins (G, M, and A). Specific anti-SARS immunoglobulins were revealed by a colorimetric probe formed by N and gold nanoparticles. Targeting the total antibodies response to infection enabled achieving 100% diagnostic specificity (95.75–100, C.I. 95%, n = 85 healthy and with other infections individuals) and 94.6% sensitivity (84.9–98.9, C.I. 95%, n = 62 SARS CoV-2 infected subjects) as early as 7 days post confirmation of positivity. Agreeing results with a reference serological ELISA were achieved, except for the earlier detection capability of the rapid test. Follow up of the three seroconverting patients endorsed the hypothesis of the random rise of the different immunoglobulins and strengthened the ‘total antibodies’ approach for the trustworthy detection of serological response to SARS CoV-2 infection

A multitarget lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2

Simone Cavalera
First
;
Barbara Colitti;Sergio Rosati;Luigi Bertolotti;Chiara Nogarol;Celeste Cagnazzo;Marco Denina;Franca Fagioli;Fabio Di Nardo;Matteo Chiarello;Claudio Baggiani;Laura Anfossi
2021

Abstract

rapid test for detecting total immunoglobulins directed towards the nucleocapsid protein (N) of severe acute syndrome coronavirus 2 (SARS CoV-2) was developed, based on a multi-target lateral flow immunoassay comprising two test lines. Both test lines bound to several classes of immunoglobulins (G, M, and A). Specific anti-SARS immunoglobulins were revealed by a colorimetric probe formed by N and gold nanoparticles. Targeting the total antibodies response to infection enabled achieving 100% diagnostic specificity (95.75–100, C.I. 95%, n = 85 healthy and with other infections individuals) and 94.6% sensitivity (84.9–98.9, C.I. 95%, n = 62 SARS CoV-2 infected subjects) as early as 7 days post confirmation of positivity. Agreeing results with a reference serological ELISA were achieved, except for the earlier detection capability of the rapid test. Follow up of the three seroconverting patients endorsed the hypothesis of the random rise of the different immunoglobulins and strengthened the ‘total antibodies’ approach for the trustworthy detection of serological response to SARS CoV-2 infection
223
121737
121744
Simone Cavalera; Barbara Colitti; Sergio Rosati; Gianmarco Ferrara; Luigi Bertolotti; Chiara Nogarol; Cristina Guiotto; Celeste Cagnazzo; Marco Denina; Franca Fagioli; Fabio Di Nardo; Matteo Chiarello; Claudio Baggiani; Laura Anfossi
File in questo prodotto:
File Dimensione Formato  
tal21_223_121737.pdf

Accesso riservato

Descrizione: paper
Tipo di file: PDF EDITORIALE
Dimensione 3.06 MB
Formato Adobe PDF
3.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
tal21_223_121737_draft.pdf

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 1.38 MB
Formato Adobe PDF
1.38 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1762789
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 40
social impact